首页 正文

Dupilumab for Moderate-to-Severe Atopic Dermatitis

{{output}}
Atopic dermatitis (AD) is the most common chronic inflammatory disease affecting 2-10% of adults and up to 15-30% of children. Despite a rising prevalence, effective and safe therapeutics for patients with moderate-to-severe AD are limited due to toxicity and ... ...